These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11641113)

  • 1. Physiological elevation in plasma angiotensinogen increases blood pressure.
    Klett CP; Granger JP
    Am J Physiol Regul Integr Comp Physiol; 2001 Nov; 281(5):R1437-41. PubMed ID: 11641113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and renin-angiotensin system resetting in transgenic rats with elevated plasma Val5-angiotensinogen.
    Bohlender J; Bader M; Ménard J; Nussberger J
    J Hypertens; 2012 Aug; 30(8):1597-605. PubMed ID: 22728903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II.
    Schunkert H; Ingelfinger JR; Jacob H; Jackson B; Bouyounes B; Dzau VJ
    Am J Physiol; 1992 Nov; 263(5 Pt 1):E863-9. PubMed ID: 1443118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice.
    Cholewa BC; Mattson DL
    Exp Physiol; 2005 Jul; 90(4):607-12. PubMed ID: 15833753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the intrahepatic renin-angiotensin system after stimulation of the gastric sodium monitor in the rat.
    Ye VZ; Duggan KA
    Clin Sci (Lond); 2000 Jan; 98(1):57-64. PubMed ID: 10600659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac angiotensinogen and its local activation in the isolated perfused beating heart.
    Lindpaintner K; Jin MW; Niedermaier N; Wilhelm MJ; Ganten D
    Circ Res; 1990 Sep; 67(3):564-73. PubMed ID: 2204498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salt-sensitive hypertension resulting from nitric oxide synthase inhibition is associated with loss of regulation of angiotensin II in the rat.
    Hodge G; Ye VZ; Duggan KA
    Exp Physiol; 2002 Jan; 87(1):1-8. PubMed ID: 11805851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen.
    Tokita Y; Franco-Saenz R; Reimann EM; Mulrow PJ
    Hypertension; 1994 Apr; 23(4):422-7. PubMed ID: 8144210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation.
    Ohtani R; Ohashi Y; Muranaga K; Itoh N; Okamoto H
    Life Sci; 1989; 44(3):237-41. PubMed ID: 2644507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen.
    Tomita N; Morishita R; Higaki J; Aoki M; Nakamura Y; Mikami H; Fukamizu A; Murakami K; Kaneda Y; Ogihara T
    Hypertension; 1995 Jul; 26(1):131-6. PubMed ID: 7541778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in central and peripheral renin-angiotensin system after furosemide injection.
    Suzuki H; Saruta T; Ferrario CM
    Endocrinol Jpn; 1986 Aug; 33(4):497-503. PubMed ID: 3539582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrectomy, converting enzyme inhibition, and angiotensin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1993 Oct; 22(4):513-22. PubMed ID: 8406656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human prorenin in rats transgenic for human angiotensinogen.
    Müller DN; Hilgers KF; Mathews S; Breu V; Fischli W; Uhlmann R; Luft FC
    Hypertension; 1999 Jan; 33(1 Pt 2):312-7. PubMed ID: 9931122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High human renin hypertension in transgenic rats.
    Bohlender J; Fukamizu A; Lippoldt A; Nomura T; Dietz R; Ménard J; Murakami K; Luft FC; Ganten D
    Hypertension; 1997 Jan; 29(1 Pt 2):428-34. PubMed ID: 9039138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human renin by rat plasma. Rat angiotensinogen is a competitive inhibitor of the human renin-substrate interaction.
    Gahnem F; Sealey JE; Atlas SA; Laragh JH
    Am J Hypertens; 1992 Aug; 5(8):495-501. PubMed ID: 1388958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma angiotensinogen in rats with experimentally induced nephrosis.
    Yayama K; Konishi K; Ohta A; Takano M; Ohtani R; Itoh N; Okamoto H
    Nephron; 1993; 63(1):89-93. PubMed ID: 8446257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identical hemodynamic and hormonal responses to 14-day infusions of renin or angiotensin II in conscious rats.
    Hu L; Catanzaro DF; Pitarresi TM; Laragh JH; Sealey JE
    J Hypertens; 1998 Sep; 16(9):1285-98. PubMed ID: 9746116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
    Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
    J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoneutralization of human angiotensin-(1-12) with a monoclonal antibody in a humanized model of hypertension.
    Ferrario CM; VonCannon JL; Zhang J; Figueroa JP; Wright KN; Groban L; Saha A; Meredith JW; Ahmad S
    Peptides; 2022 Mar; 149():170714. PubMed ID: 34933010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.